Skip to Main Content

Paper Details

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Human Pathology
23
2019
CDH1, PUC, TERT, TERT promoter, TP53, UC, UC) of the bladder, bladder cancer, cadherin 1, cadherin 1 (CDH1) gene, g, kirsten rat sarcoma, kirsten rat sarcoma (KRAS) viral proto-oncogene, mutated genes, patients, plasmacytoid, plasmacytoid urothelial carcinoma, plasmacytoid variant of urothelial carcinoma, promoter, rat, telomerase reverse transcriptase, telomerase reverse transcriptase (TERT) gene, tumor protein p53, tumors, urothelial carcinoma
Author NameAffiliation
Kenneth W KinzlerJohns Hopkins University, USA The Ludwig Center for Cancer Genetics and Therapeutics and Sidney Kimmel Comprehensive Cancer Center
Nickolas PapadopoulosJohns Hopkins University, USA The Ludwig Center for Cancer Genetics and Therapeutics and Sidney Kimmel Comprehensive Cancer Center
Bert VogelsteinJohns Hopkins University, USA The Ludwig Center for Cancer Genetics and Therapeutics and Sidney Kimmel Comprehensive Cancer Center
  • 1 - 3

Datasets

Release 1.2